Bulgarian Pharmaceutical Group Ltd.

 

BPG Ltd.
www.bpg.bg
 
 

May you have interesting time visiting us!

 

Advanced search


Cosmetics
Essential oils
Natural Products
Pharmaceuticals

Substances
Oral hygiene

 

 
   
 
-
Tribestan ® (Tribulus)  
 
Tribulus Clinical Study
Tribulus Introduction
Chemical & Physical Properties of Tribulus
Tribulus pharmacological studies
Clinical trials with Tribulus
Tribulus Studies in Females with Endocrine Sterility and Postmenopausal Syndrome
Table of contents
References
 
Company Documentation
Summary on Tribestan
Pharmacokinetic Studies
Effect on some Hormone Concentrations
Clinical testing
Clinical treatment in women with Climacteric Syndrome
Studies on Females with Endocrine Sterility
Comparative study on Tribulus preparations
 
The Author
Application
 
Distributors
Side effect
-
-
Order online  

Tribestan 60 tabl x 250 mg
Tribulus 250 mg per tablet

PB(3,5)

-
 
 
 

tribestan home / supplements

 
 
 
Tribulus Terrestris, Tribestan, erections, infertility, ovulation, pms, muscle mass, impotence, testosterone, sterility, sex
(Tribulus)

 

TABLE OF CONTENTS

TABLE OF CONTENTS

INTRODUCTION

    General information on Tribestan

1. CHEMICAL AND PHYSICAL PROPERTIES

2. PHARMACOLOGICAL STUDIES

    2.1. Methods characterizing the stimulating effect on spermatogenesis
    2.2. Effect on DNA synthesis in gonocytes
    2.3. Effect on Leydig and Sertoli cells in the testes
    2.4. Effect on concentration, motility and survival of spermatozoa
    2.5. Effect on the sexual libido
    2.6. Studies on serum concentration of the hormones from the hypophyseal-gonadal axis
    2.7. Effect on the central nervous system
    2.8. Effect on the cardiovascular system
    2.9. Pharmacokinetic studies
    2.10. Toxicological studies (G.Tanev, S.Zarkova, 1980)
    2.10.1. Acute toxicity
    2.10.2. Subacute toxicity
    2.10.3. Chronic toxicity
    2.11. Discussion of the results

3. CLINICAL STUDIES

    3.1. Materials and methods
    3.2. Results
    3.3. Tolerance and side effects
    3.4. Discussion of the results

4. CLINICAL STUDIES IN FEMALES WITH ENDOCRINE INFERTILITY OR POSTMENOPAUSAL SYNDROME

    4.1. Parameters observed and evaluated
    4.2. Results and discussion
    4.3. Side effect in treatment with Tribestan
    CONCLUSION

REFERENCES

 

Rose Cosmetics | Lady's Joy Cosmetics | Reproductive system


home | mailing list | about us

 

© 1998 - 2006 Bulgarian Pharmaceutical Group Ltd. All Rights Reserved.